Suppr超能文献

Should we expand treatment initiation for chronic hepatitis B infection? Cons.

作者信息

Chen Chien-Hung

机构信息

Department of Internal Medicine, Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

Clin Liver Dis (Hoboken). 2024 Apr 2;23(1):e0141. doi: 10.1097/CLD.0000000000000141. eCollection 2024 Jan-Jun.

Abstract
摘要

相似文献

1
Should we expand treatment initiation for chronic hepatitis B infection? Cons.
Clin Liver Dis (Hoboken). 2024 Apr 2;23(1):e0141. doi: 10.1097/CLD.0000000000000141. eCollection 2024 Jan-Jun.
2
Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America.
JAMA Netw Open. 2023 Apr 3;6(4):e237018. doi: 10.1001/jamanetworkopen.2023.7018.
4
5
Treatment of chronic hepatitis B in children.
J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S56-60. doi: 10.1097/01.mpg.0000226391.02355.1b.
6
Antiviral therapy for chronic hepatitis B: a review.
Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):63-70. doi: 10.2174/1568010043483908.
8
Perspectives on current controversial issues in the management of chronic HBV infection.
J Gastroenterol. 2022 Nov;57(11):828-837. doi: 10.1007/s00535-022-01918-z. Epub 2022 Sep 2.
9
[Interdisciplinary aspects of and new drugs for chronic hepatitis B].
Orv Hetil. 2013 Jul 21;154(29):1142-50. doi: 10.1556/OH.2013.29625.
10
Rate and determinants of antiviral treatment initiation for patients with HBeAg-negative chronic hepatitis B.
J Viral Hepat. 2023 Aug;30(8):694-699. doi: 10.1111/jvh.13841. Epub 2023 Jun 1.

本文引用的文献

1
Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase.
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1803-1812.e5. doi: 10.1016/j.cgh.2021.01.019. Epub 2021 Jan 16.
2
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
Hepatology. 2021 Jun;73(6):2124-2140. doi: 10.1002/hep.31554. Epub 2021 May 21.
3
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase.
Aliment Pharmacol Ther. 2020 Jul;52(1):196-204. doi: 10.1111/apt.15741. Epub 2020 May 26.
4
Should Treatment Indications for Chronic Hepatitis B Be Expanded?
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2006-2014. doi: 10.1016/j.cgh.2020.04.091. Epub 2020 May 17.
5
Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone.
Aliment Pharmacol Ther. 2018 May;47(10):1397-1408. doi: 10.1111/apt.14613. Epub 2018 Mar 25.
7
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
Gut. 2018 May;67(5):945-952. doi: 10.1136/gutjnl-2017-314904. Epub 2017 Oct 21.
8
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
10
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.
Hepatol Int. 2016 Jan;10(1):1-98. doi: 10.1007/s12072-015-9675-4. Epub 2015 Nov 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验